Wolf Popper LLP Announces Investigation on Behalf of Purchasers of FibroGen, Inc. (FGEN) Common StockPRNewsWire • 04/07/21
California Office of Berman Tabacco Launches Investigation into Potential Securities Claims Against FibroGen Inc. (FGEN) In Connection with Roxadustat "Clarification"Newsfile Corp • 04/07/21
SHAREHOLDER ALERT: Investigation of FibroGen, Inc. Announced by Holzer & Holzer, LLCNewsfile Corp • 04/07/21
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of FibroGen Inc. (FGEN) on Behalf of InvestorsBusiness Wire • 04/07/21
(FGEN) Alert: Did You Lose Money on Your FibroGen Investment? Contact Johnson Fistel Regarding InvestigationPRNewsWire • 04/07/21
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of FibroGen Inc. (FGEN) on Behalf of InvestorsBusiness Wire • 04/07/21
FibroGen Stock Is Trading Lower As CEO Admits Manipulated Safety Data For RoxadustatBenzinga • 04/07/21
The Law Offices of Frank R. Cruz Announces Investigation of FibroGen Inc. (FGEN) on Behalf of InvestorsBusiness Wire • 04/07/21
FibroGen Announces FDA Advisory Committee to Review Roxadustat New Drug Application Tentatively Scheduled for July 15, 2021GlobeNewsWire • 04/06/21
Investors Who Have Lost Money in Their FibroGen Investment Should Contact Block & Leviton, Who Is Investigating Securities Fraud Claims Against FibroGenNewsfile Corp • 04/06/21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FibroGen, Inc. - FGEPRNewsWire • 03/24/21
FibroGen Initiates LELANTOS-2 – Second Phase 3 Clinical Study of Pamrevlumab for the Treatment of Duchenne Muscular DystrophyGlobeNewsWire • 03/16/21
FibroGen Stock Collapses After Its Latest-Stage Drug Faces Another DelayInvestors Business Daily • 03/02/21
FibroGen's (FGEN) CEO Enrique Conterno on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/02/21
FibroGen (FGEN) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 02/22/21